INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 18, 2022 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Bona fide gift | 335 | -- | 52,795 |
| Jan 04, 2022 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 338 | -- | 141,292 |
| Oct 04, 2021 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 347 | -- | 141,630 |
| Aug 09, 2021 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 17,000 | -- | 291,090 |
| Jul 02, 2021 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 373 | -- | 141,977 |
| Jun 24, 2021 |
Director, President and Chief Scientific
Trans History: 617
|
Director, President and Chief Scientific | Form 4 | Bona fide gift | 211,585 | -- | 213,693 |
| Jun 24, 2021 |
Director, President and Chief Scientific
Trans History: 617
|
Director, President and Chief Scientific | Form 4 | Bona fide gift | 211,585 | -- | -- |
| Jun 14, 2021 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 19,000 | -- | 308,090 |
| May 27, 2021 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 22,000 | -- | 327,090 |
| May 19, 2021 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Bona fide gift | 41,178 | -- | 41,178 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.